8-K - BiomX Inc. | StockGist

AI Analysis

AI-generated analysis. Always verify with the original filing.

On February 9 and 11, 2026, Directors Jonathan Leff and Jesse Goodman resigned from the BiomX Inc. Board for personal reasons. On February 13, 2026, the Board appointed Liat Bidas as a Class II Director with a term expiring in 2028.

Key Takeaways

1Jonathan Leff resigned from the Board of Directors on February 9, 2026, effective immediately, for personal reasons.

2Jesse Goodman resigned from the Board of Directors on February 11, 2026, effective immediately, for personal reasons.

3Neither departing director advised the Company of any disagreement regarding operations, policies, or practices.

4Liat Bidas was appointed as a Class II Director on February 13, 2026, with a term expiring at the 2028 annual meeting.

5Ms. Bidas is a Managing Partner at UpStream Capital Group and serves as a director of BioView on the Tel Aviv Stock Exchange.

6The Board determined Ms. Bidas is independent under NYSE American LLC rules.

Current Report Details

Event Type

Management Change

Disclosure

Mandatory

Variant

8-K

Items Reported

5.02

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensation Arrangements of Certain Officers. On February 9

Management Change

Company on any matter relating to its operations, policies or practices. The CompanyMs. Bidas on substantially the same terms as the agreements previously entered into between the Company

Executive & Director Changes

Jonathan Leff

Director

Resignation

Effective: 2026-02-09

Personal reasons

Jesse Goodman

Director

Resignation

Effective: 2026-02-11

Personal reasons

Liat Bidas

Class II Director

Appointment

Effective: 2026-02-13

To fill vacancy on the Board

Exhibits (1)

8-K

CURRENT REPORT